YouTubers

Dr. Mike Varshavski Partners With UNICEF to Answer Most Common Coronavirus Questions on Vaccine Development

Retrieved on: 
Wednesday, April 7, 2021

-- are minimal, and agreed with Dr. Mike Varshavski when he said it might be better to call them "intended effects."

Key Points: 
  • -- are minimal, and agreed with Dr. Mike Varshavski when he said it might be better to call them "intended effects."
  • The greater concern is the impact of variants, which Nandy defined as small changes in the genetic structure of the virus.
  • About Doctor Mike Media: Doctor Mike Media is a health & lifestyle organization launched by Dr. Mike Varshavski.
  • With over 16 million social media followers, Dr. Mikhail Varshavski, commonly known as "Doctor Mike" is a multifaceted board-certified family medicine physician, media personality, educator, writer, and philanthropist.

EyeBuyDirect Taps Lele Pons As New Brand Ambassador

Retrieved on: 
Tuesday, April 6, 2021

LOS ANGELES, April 6, 2021 /PRNewswire/ -- EyeBuyDirect , the leading online retailer for prescription eyewear, has announced a partnership with singer, actress and global entertainer, Lele Pons.

Key Points: 
  • LOS ANGELES, April 6, 2021 /PRNewswire/ -- EyeBuyDirect , the leading online retailer for prescription eyewear, has announced a partnership with singer, actress and global entertainer, Lele Pons.
  • As the new Brand Ambassador, Pons will support the launch of EyeBuyDirect's upcoming collections this summer and leverage her social media platforms to raise awareness of the brand's mission and values.
  • "I'm thrilled to be partnering with EyeBuyDirect as their Brand Ambassador!
  • I truly believe in their mission to make eyewear more accessible while also encouraging people to celebrate their beautyinside and out," said Pons.

Dan Bongino To Helm New Radio Program For Westwood One

Retrieved on: 
Thursday, March 18, 2021

The Dan Bongino Show will tackle the hot political issues, debunking both liberal and Republican establishment rhetoric.

Key Points: 
  • The Dan Bongino Show will tackle the hot political issues, debunking both liberal and Republican establishment rhetoric.
  • With the launch of The Dan Bongino Show, Westwood One now offers a 24-hour, MondayFriday news/talk lineup that also features established news/talk superstars Mark Levin, Ben Shapiro, Chris Plante, and Jim Bohannon.
  • Bongino has attracted an impressive and loyal following since he left the Secret Service in 2011 and became a media personality.
  • "I'm excited to embrace the immense power of radio to connect with my listeners live for three hours every day," said Bongino.

EyeBuyDirect Launches Nature Harmony Collection

Retrieved on: 
Tuesday, March 16, 2021

LOS ANGELES, March 16, 2021 /PRNewswire/ -- EyeBuyDirect , the leading online retailer for prescription eyewear, is continuing its sustainable efforts with the announcement of the Nature Harmony collection.

Key Points: 
  • LOS ANGELES, March 16, 2021 /PRNewswire/ -- EyeBuyDirect , the leading online retailer for prescription eyewear, is continuing its sustainable efforts with the announcement of the Nature Harmony collection.
  • To celebrate the launch of Nature Harmony, the eyewear brand has partnered with popular social media influencer Natalie Mariduena for an Instagram giveaway.
  • Nature Harmony's design was inspired by the colors and shades found in nature, while also emphasizing the importance of recycling and repurposing.
  • The launch of Nature Harmony continues EyeBuyDirect's "Eyewear Sustainability" campaign and focus on earth-friendly products following the introduction of 5 to See last year.

Rubius Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, February 23, 2021

Net loss for the fourth quarter of 2020 was $40.5 million or $0.50 per common share, compared to $44.5 million or $0.56 per common share in the fourth quarter of 2019.

Key Points: 
  • Net loss for the fourth quarter of 2020 was $40.5 million or $0.50 per common share, compared to $44.5 million or $0.56 per common share in the fourth quarter of 2019.
  • In the fourth quarter of 2020, Rubius invested $25.6 million in research and development (R&D) related to its novel RED PLATFORM and towards expanding and advancing its product pipeline, as compared to $30.5 million in the fourth quarter of 2019.
  • G&A expenses were $14.1 million during the fourth quarter of 2020, as compared to $14.9 million for the fourth quarter of 2019.
  • Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeutics.

Industry-Leading CBD Company cbdMD Renews Exclusive Partnership with The Pat McAfee Show

Retrieved on: 
Friday, February 19, 2021

Through the renewed partnership, cbdMD will continue its role as an official CBD sponsor of the The Pat McAfee Show, as well as a recurring sponsor of the show's weekly "Feel Good Friday" episodes.

Key Points: 
  • Through the renewed partnership, cbdMD will continue its role as an official CBD sponsor of the The Pat McAfee Show, as well as a recurring sponsor of the show's weekly "Feel Good Friday" episodes.
  • "We're delighted to extend our exclusive partnership and continue joining forces with The Pat McAfee Show, as it grants us a unique opportunity to promote the overarching benefits of CBD and our brand's award-winning products.
  • cbdMD, Inc. is one of the world's leading, most highly trusted health and wellness CBD companies, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD botanical skincare products, CBD bath bombs, and CBD pet products.
  • On The Pat McAfee Show, Pat McAfee and his friends deliver one of a kind opinions that won't be heard anywhere else.

Rubius Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results

Retrieved on: 
Tuesday, February 9, 2021

CAMBRIDGE, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc.(Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is using its platform to genetically engineer red blood cells into medicines, called Red Cell Therapeutics, for the treatment of cancer and autoimmune diseases, today announced plans to report fourth quarter and full year 2020 financial results onTuesday, February 23, 2021, before market open.

Key Points: 
  • CAMBRIDGE, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc.(Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is using its platform to genetically engineer red blood cells into medicines, called Red Cell Therapeutics, for the treatment of cancer and autoimmune diseases, today announced plans to report fourth quarter and full year 2020 financial results onTuesday, February 23, 2021, before market open.
  • The company will not be hosting a teleconference in conjunction with its financial results press release.
  • Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeutics.
  • Rubius Therapeutics manufacturing site was recently named 2020 Top 5 Best Places to Work in Rhode Island among medium-sized companies by Providence Business News.

Global Creator Company Jellysmack Partners with PewDiePie to Distribute his Popular YouTube Content on Facebook

Retrieved on: 
Wednesday, January 13, 2021

LOS ANGELES, Jan. 13, 2021 /PRNewswire/ --Jellysmack, the global creator company, and Swedish gamer, comedian and entrepreneur Felix Arvid Ulf Kjellberg, known online as PewDiePie, have signed an exclusive worldwide deal to distribute PewDiePie's on-demand YouTube content to Facebook for the first time.

Key Points: 
  • LOS ANGELES, Jan. 13, 2021 /PRNewswire/ --Jellysmack, the global creator company, and Swedish gamer, comedian and entrepreneur Felix Arvid Ulf Kjellberg, known online as PewDiePie, have signed an exclusive worldwide deal to distribute PewDiePie's on-demand YouTube content to Facebook for the first time.
  • Jellysmack works across social platforms, including Facebook, Instagram, Snapchat, TikTok, Twitter and YouTube, leveraging its proprietary data and optimization tools to broaden a creator's presence and revenue potential.
  • The multi-year partnership to activate and expand Kjellberg's Facebook audience represents the first of its kind for the creator.
  • Currently home to over 100 influential Creators including PewDiePie, Brad Mondo, and Bailey Sarian, Jellysmack optimizes, operates, and distributes creator-made video content to Facebook, Instagram, Snapchat, TikTok, Twitter, and YouTube.

Rubius Therapeutics Provides Operational Update and Outlines 2021 Objectives at the 39th Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Monday, January 11, 2021

Pablo J. Cagnoni, M.D., chief executive officer, will present these updates and review 2020 achievements on Wednesday, January 13, 2021, at 8:20 a.m. EST at the virtual 39th Annual J.P. Morgan Healthcare Conference.

Key Points: 
  • Pablo J. Cagnoni, M.D., chief executive officer, will present these updates and review 2020 achievements on Wednesday, January 13, 2021, at 8:20 a.m. EST at the virtual 39th Annual J.P. Morgan Healthcare Conference.
  • Rubius Therapeutics made significant progress in advancing our oncology pipeline and in-house manufacturing capabilities in 2020, said Pablo J. Cagnoni, M.D., president and chief executive officer.
  • We plan to present additional clinical results in early 2021, and we plan to submit for presentation at a scientific conference.
  • To date, Rubius has completed dosing of 5 cohorts (n=14) in the Phase 1/2 RTX-240 solid tumor clinical trial.

Spectrum Veterinary Is Now Nextmune--the Global Leader in Specialty Healthcare Dedicated to Healthy, Vibrant Pets for Life

Retrieved on: 
Monday, January 4, 2021

The operations in Italy will remain ICF and DRN and typically be referred to ICF, a Nextmune company and DRN, a Nextmune company, respectively.

Key Points: 
  • The operations in Italy will remain ICF and DRN and typically be referred to ICF, a Nextmune company and DRN, a Nextmune company, respectively.
  • The rebranding comes in response to the significant growth of Nextmune lately and to better represent the companys capabilities to veterinarians and pet parents.
  • Magnus Kjellberg, CEO and co-president, and Gennaro Falanga, co-president, stated: Over the past few years, we have built up a science-driven, global business spanning 70 worldwide countries dedicated to healthy, vibrant pets for life.
  • About Nextmune: Nexmune is a science-driven, global specialty healthcare company dedicated to healthy, vibrant pets for life.